Literature DB >> 1434511

In vivo 13C-NMR evaluation of glycogen content in a patient with glycogen storage disease.

P Labrune1, P Jehenson, A Syrota, M Odièvre.   

Abstract

Glycogen storage disease was suspected in a 10-month-old boy. Initial technical problems did not permit the determination of the precise enzyme, deficiency, and type VI glycogen storage disease was only diagnosed at the age of 2 years. In the mean time, natural abundance 13C nuclear magnetic resonance evaluation of muscular and hepatic glycogen content indicated normal muscular glycogen and increased hepatic glycogen in our patient, a finding which strongly argued for the diagnosis of type VI glycogen storage disease. Even though the use of nuclear magnetic resonance might seem, in this situation, a somewhat circuitous means of reaching the diagnosis, it appears that nuclear magnetic resonance could provide a useful tool for a non-invasive diagnosis of glycogen storage diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1434511     DOI: 10.1007/bf01800013

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  10 in total

Review 1.  Pathophysiology and dietary treatment of the glycogen storage diseases.

Authors:  S W Moses
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-08       Impact factor: 2.839

2.  Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience.

Authors:  I Maire; C Baussan; N Moatti; M Mathieu; A Lemonnier
Journal:  Clin Biochem       Date:  1991-04       Impact factor: 3.281

3.  Diagnosis of glycogen storage disease.

Authors:  Y S Shin
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

4.  Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values.

Authors:  R C Harris; E Hultman; L O Nordesjö
Journal:  Scand J Clin Lab Invest       Date:  1974-04       Impact factor: 1.713

5.  Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance.

Authors:  B D Ross; G K Radda; D G Gadian; G Rocker; M Esiri; J Falconer-Smith
Journal:  N Engl J Med       Date:  1981-05-28       Impact factor: 91.245

6.  Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure.

Authors:  M J Sullivan; H J Green; F R Cobb
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

7.  Detection of human muscle glycogen by natural abundance 13C NMR.

Authors:  M J Avison; D L Rothman; E Nadel; R G Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

8.  Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis.

Authors:  D Duboc; P Jehenson; S Tran Dinh; C Marsac; A Syrota; M Fardeau
Journal:  Neurology       Date:  1987-04       Impact factor: 9.910

9.  Diagnosis of muscular glycogenosis by in vivo natural abundance 13C NMR spectroscopy.

Authors:  P Jehenson; D Duboc; G Bloch; M Fardeau; A Syrota
Journal:  Neuromuscul Disord       Date:  1991       Impact factor: 4.296

10.  Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy.

Authors:  D L Arnold; D J Taylor; G K Radda
Journal:  Ann Neurol       Date:  1985-08       Impact factor: 10.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.